GLP1R and Hyperglycemia: On the other hand, there is active consideration for the use of glucagon-like peptide 1 receptor agonists (exenatide, liraglutide, dulaglutide) in the setting of calcineurin inhibition or tacrolimus-related hyperglycemia [72,73].